How to Choose a Transplant Hospital Abroad: 10 Questions Patients Should Ask

Choosing a hospital for an organ transplant is a major medical decision. Choosing one in another country adds another layer of complexity.

International patients may need to compare transplant programs, understand eligibility requirements, determine whether a hospital accepts non-resident patients, organize medical records, evaluate living-donor requirements and plan for follow-up after returning home.

For these reasons, searching for the “best transplant hospital abroad” should not simply mean finding the hospital with the lowest price, the shortest advertised waiting time or the most impressive website.

The more useful question is:

Which transplant center is appropriate for this particular patient, transplant pathway and clinical situation?

The answer can only emerge through proper hospital evaluation.

Here are 10 important questions patients and their families should ask before pursuing transplant care internationally.

1. Does the hospital have an established program for the transplant you need?

Not every hospital that offers transplantation performs every type of transplant.

A center may have extensive experience in kidney transplantation but not perform heart or lung transplantation. Another may specialize in liver transplantation, pediatric cases, hematopoietic stem cell transplantation or particular complex conditions.

Start by confirming the specific transplant program, not simply whether the institution describes itself as a transplant hospital.

Patients may need to consider programs involving:

kidney transplantation;

liver transplantation;

heart transplantation;

lung transplantation;

pancreas transplantation;

or hematopoietic stem cell/bone marrow transplantation.

Different procedures involve different eligibility criteria, infrastructure and regulatory requirements.

For this reason, MedTransplant organizes international enquiries around transplant pathways, rather than treating transplantation as a single medical service.

2. Does the transplant center accept international patients?

A hospital performing transplantation for domestic patients does not necessarily accept patients who live abroad.

Policies concerning international patients can depend on the organ involved, donor pathway, national legislation, organ-allocation rules and the hospital's own policies.

This is particularly important in deceased-donor transplantation.

A patient should never assume that because a transplant procedure is performed in a country, the same pathway is automatically available to a foreign patient.

Ask the center:

Do you evaluate international patients for this particular type of transplantation?

This question should be answered before major travel arrangements are made.

3. Who decides whether the patient is eligible for transplantation?

Eligibility should be determined by the transplant center after appropriate medical assessment.

A legitimate facilitator, referral organization or international patient department can help patients communicate with hospitals and submit records, but it should not independently promise that a patient will receive a transplant.

A transplant program may consider factors such as the underlying disease, disease severity, other medical conditions, infection status, previous treatments, surgical history and the patient's ability to undergo transplantation and post-transplant care.

The exact criteria vary considerably according to transplant type and individual circumstances.

A referral is therefore not the same as acceptance for transplantation.

4. What medical records should be reviewed before travel?

Whenever possible, patients should determine whether the hospital can conduct an initial remote review of medical records before international travel.

This can be particularly valuable.

Travelling internationally only to discover that important information is missing—or that the requested transplant pathway is not appropriate—can impose unnecessary financial and emotional burdens on patients and families.

Depending on the case, the hospital may request:

specialist reports;

diagnosis and medical history;

laboratory results;

imaging and imaging reports;

pathology results;

current medications;

previous surgery or treatment records;

dialysis information for kidney patients;

or other transplant-specific investigations.

An initial record review does not establish final eligibility, but it can help determine the appropriate next step.

International case referral

MedTransplant allows a patient—or a family member or trusted representative acting on the patient's behalf—to provide initial case information and available medical documents for referral navigation.

Where an appropriate pathway can be identified, the objective is to facilitate independent evaluation by a relevant transplant hospital.

5. If a living donor is involved, how is the donor evaluated and protected?

This is one of the most important questions in international transplantation.

A potential living donor should never be treated simply as a way to obtain an organ for the recipient.

WHO's Guiding Principles emphasize that living donation requires informed and voluntary consent and appropriate medical and psychosocial safeguards.

The transplant center should have procedures for evaluating the potential donor independently.

Patients should ask:

• Who evaluates the donor?
• How is medical suitability assessed?
• Is psychosocial evaluation performed?
• How does the hospital establish that consent is voluntary?
• How is potential coercion or financial pressure addressed?
• What follow-up is available for the donor?

A donor's welfare remains important even when transplantation could substantially benefit the recipient.

6. How does the hospital protect against organ trafficking and unethical transplantation?

This question should never be considered impolite.

It is an essential part of responsible international transplant planning.

The Declaration of Istanbul distinguishes legitimate travel for transplantation from transplant tourism involving organ trafficking, trafficking in persons for organ removal, or circumstances in which transplantation for non-residents undermines a country's ability to provide transplant services to its own population.

Patients should avoid anyone offering:

“guaranteed organs,” commercially sourced donors, payment for an organ, anonymous donor arrangements that cannot be properly explained, or methods intended to bypass transplant regulations.

A reputable transplant program should be able to explain its donor, ethical and regulatory procedures.

MedTransplant does not sell, source or broker human organs.

7. What experience does the transplant program have?

Hospital reputation alone does not tell you everything about an individual transplant program.

Patients should look more specifically at the program relevant to their condition.

Useful questions can include:

• How long has the transplant program been operating?
• Which types of transplant does it perform?
• Does it manage complex or high-risk cases?
• Does it have dedicated transplant physicians, surgeons and coordinators?
• What critical-care facilities support transplant patients?
• How does it report transplant outcomes where such information is publicly available?

Outcome statistics also require careful interpretation.

A higher or lower numerical success rate cannot necessarily be compared directly between hospitals without understanding differences in patient populations, case complexity, definitions and follow-up periods.

Therefore, patients should avoid choosing a hospital based on one percentage displayed on a marketing page.

8. What happens after the transplant?

Transplantation does not end when the patient leaves the operating room—or even when the patient leaves the country.

Post-transplant management may involve:

immunosuppressive medications;

laboratory monitoring;

infection surveillance;

organ-function monitoring;

wound care;

medication adjustment;

management of rejection or other complications;

and communication between the transplant center and physicians in the patient's home country.

Before selecting a transplant hospital abroad, ask:

• How long must I remain near the transplant center?
• What follow-up will occur before I travel home?
• What records will be provided to my physician?
• Can my doctor communicate with the transplant team after I return?
• What happens if a complication develops after I leave the country?

The answers may materially affect which international transplant center is appropriate.

9. What is actually included in the estimated cost?

Cost matters—but it should be evaluated correctly.

An initial estimate may or may not include the full transplant pathway.

Patients should determine whether estimates include:

initial consultation and evaluation;

additional diagnostic testing;

donor evaluation where applicable;

hospitalization;

surgery;

intensive-care treatment;

medications during hospitalization;

accommodation;

post-transplant testing;

management of unexpected complications;

or extended hospitalization.

The least expensive initial quote may therefore not represent the lowest total cost of care.

Patients should also be cautious when a third party requests payment for an organ itself.

WHO's Guiding Principles state that cells, tissues and organs should be donated freely, without monetary payment or other reward of monetary value, while permitting legitimate reimbursement of reasonable and verifiable expenses and payment for professional services.

Hospital treatment costs and purchasing a human organ are fundamentally different things.

10. What happens if the hospital says “no”?

This question is often overlooked.

A transplant center may determine after reviewing records—or after a comprehensive evaluation—that transplantation is not appropriate at that time.

That decision may relate to clinical risk, transplant-specific criteria, donor suitability, regulatory restrictions or other factors.

Patients should understand what happens next.

• Can additional information be submitted?
• Can another transplant pathway be considered?
• Would another specialist opinion be reasonable?
• Is the patient temporarily ineligible or permanently unsuitable under that program's criteria?

A responsible international navigation process should help the patient understand the next legitimate step rather than promise a way around a transplant center's decision.

How should patients compare transplant hospitals in different countries?

Country and hospital should be considered separately.

A country may have several transplant centers with very different programs, specialties and international-patient policies.

Conversely, a famous hospital may not provide the particular transplant pathway needed by an individual patient.

A practical sequence is:

rather than:

MedTransplant therefore provides destination and hospital information as part of a broader international transplant navigation process.

Warning signs when searching for a transplant hospital abroad

Patients and families should exercise particular caution when they encounter claims such as:

• “We guarantee you a kidney.”
• “No donor evaluation is necessary.”
• “You can purchase a donor.”
• “We can bypass the waiting system.”
• “Acceptance is guaranteed before the hospital reviews your medical records.”
• “Do not tell your doctors where the organ came from.”

These are fundamentally different from a legitimate offer to review a patient's case for possible transplantation.

International transplant care should preserve the rights and safety of both recipients and donors.

How MedTransplant helps patients identify an appropriate pathway

Searching internationally can become confusing very quickly.

A patient may find dozens of hospitals, conflicting claims, different national regulations and different requirements for international patients.

MedTransplant is designed to provide international transplant care navigation and patient referral support, rather than to make transplant decisions itself.

The process can begin with identifying the transplant pathway and destination relevant to the patient's circumstances, organizing available medical information and identifying potentially relevant hospitals for independent evaluation.

MedTransplant does not determine transplant eligibility, allocate organs, sell organs, source donors or guarantee transplantation.

The final medical and transplant decisions remain with the licensed transplant center and applicable authorities.

Need help identifying a transplant hospital for your case?

A patient, family member or trusted representative can submit basic information and available medical records for an initial case review.

Continue exploring

Related MedTransplant guides

International transplant care

International Organ Transplantation: A Patient’s Guide to Safe and Ethical Care Abroad

Learn how international organ transplantation works, including eligibility, hospital evaluation, living donation, patient safety and ethical care abroad.

Read guide →

Kidney transplant

Kidney Transplant Abroad: Eligibility, Living Donors, Evaluation and Patient Safety

Considering a kidney transplant abroad? Learn about eligibility, living donor evaluation, hospital selection, safety, costs and international patient referral.

Read guide →

Living donation

Living Donor Transplantation Abroad: Medical Evaluation, Ethics and Donor Protection

Learn how living donor transplantation abroad works, including donor evaluation, consent, compatibility, ethics, legal safeguards and international patient referral.

Read guide →